and have not been controlled for in published estimates of heterosexual transmission probabilities. Furthermore, estimated transmission probabilities based only on seroconversion in serodiscordant couples are biased upward, because 13% of couples in a Zambian cohort thought to have transmitted HIV within the partnership on similar grounds had genetically unrelated infections. 12 French and colleagues also used estimates of sex partner change (1.5-4 new partners each year; their Fig. 1 and Table 1 ) much higher than observed in probability sample surveys of sub-Saharan Africans. The sources cited for their partner change estimates actually include no explicit basis for these estimates aside from "inspection" of unreferenced data 13 and nonempiric values "to generate the scale of epidemic observed." 14 The number of sex partners in the prior year cannot be used to estimate annual sex partner change, because many partnerships, especially marriages, last longer than a year.
Publicly available data from the national probability sample household Demographic and Health Surveys (www.measuredhs. com) in 11 eastern and southern African countries indicate levels of partner change that are dramatically lower than the parameter estimates used by French and colleagues. A reasonable proxy measure of annual partner change is the number of nonmarital partners reported by men in the previous year (keeping in mind that sampled women consistently reported fewer partners than men). The mean for each survey is substantially below the lowest estimate examined by French and colleagues (Table 1) . These surveys are current, but they concur with findings over the last 15 years. 15, 16 Some similar problems obtain for the model proposed by French and colleagues for medical injections. In this case, French and colleagues use transmission probabilities for medical injections that encompass the range of published estimates. 17, 18 The problem here, rather, is that the topic has been inadequately studied. The proportion of used needles in medical settings that have detectable HIV varies from 0% in needles that had been boiled at several Ethiopian clinics 19 to 33% of needles previously used by HIV-infected Cameroonians for intravenous injections. 20 Clearly, empiric experience is inadequate to understand where the true risk lies or to assess its heterogeneity or multiplicative effect on other modes of transmission. In addition, French and colleagues' allowing only one "spread" infection from a contaminated needle or syringe precludes the possibility of multiple infections arising from a single reused needle or syringe or from contaminated multidose medication vials and rinsing pans. 17 Other types of blood exposures may also be involved with HIV transmission such as blood transfusion, dental procedures, circumcision, and induced abortion.
French and colleagues' model for heterosexual transmission is similar to prior modeling efforts for sub-Saharan Africa in which parameter estimates exceeded those in the empiric record. [21] [22] [23] [24] An important contribution of these efforts has been to demonstrate the level of sexual contact and sexual transmission that would actually be needed to "generate the scale of the epidemic observed." The disjunction between those parameters and the ones observed is cause for reconsideration.
The real value of mathematical models is in raising questions about the phenomenon modeled and identifying gaps in empiric knowledge. 25 Indeed, the modeling of HIV transmission in sub-Saharan Africa highlights important gaps in epidemiologic evidence. To determine modes of transmission with confidence, researchers should trace incident cases and uninfected controls' contacts about the full spectrum of time-and place-specific sexual and nonsexual exposures and sequence infected persons' HIV isolates. 26 Such strategies are the most informative and are usually the first used for investigating emerging infections, [27] [28] [29] [30] including HIV in the United States in the early 1980s 31, 32 as well as other endemic infections such as tuberculosis. [33] [34] [35] In parallel with more comprehensive empiric evaluations, modelers might consider a more comprehensive, multifactorial approach. Not only are multiple modes and their interactions important, but the much discussed presence of adjuvants such as sexually transmitted infections (especially herpes simplex virus type 2) 36,37 or of variable transmission probabilities such as the those potentially associated with the high viral loads of acute HIV infection 38, 39 need to be considered. For example, Gray and colleagues 40 constructed a model incorporating empirically based estimates of transmission probabilities and variable viral loads from their Rakai study 4 to assess the impact of antiretroviral therapy and HIV vaccines on transmission.
Whatever questions may be raised, French and colleagues' simulations advance an important discussion and may serve as a stimulus to new investigations, both empiric and theoretical, that deal with an increasingly complex and recalcitrant problem. 
